{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/Library/Frameworks/Python.framework/Versions/3.5/lib/python3.5/site-packages/requests/__init__.py:91: RequestsDependencyWarning: urllib3 (1.24.1) or chardet (2.3.0) doesn't match a supported version!\n",
      "  RequestsDependencyWarning)\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "ClarityNLP notebook helpers loaded successfully!\n"
     ]
    }
   ],
   "source": [
    "# Import dependencies\n",
    "%matplotlib inline\n",
    "import pandas as pd\n",
    "import numpy as np\n",
    "import os \n",
    "from collections import OrderedDict\n",
    "pd.set_option('display.width',100000)\n",
    "pd.set_option('max_colwidth',4000)\n",
    "import matplotlib.pyplot as plt\n",
    "import xml.etree.ElementTree\n",
    "import spacy\n",
    "from spacy.matcher import Matcher\n",
    "import textacy\n",
    "\n",
    "FDA_DIR = \"/Users/charityhilton/repos/FDA_AE_challenge_2019\"\n",
    "\n",
    "\n",
    "import claritynlp_notebook_helpers as claritynlp"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Unnamed: 0</th>\n",
       "      <th>file</th>\n",
       "      <th>len</th>\n",
       "      <th>reason</th>\n",
       "      <th>type</th>\n",
       "      <th>meddra_llt</th>\n",
       "      <th>meddra_pt</th>\n",
       "      <th>meddra_pt_id</th>\n",
       "      <th>description</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>0</td>\n",
       "      <td>impavido</td>\n",
       "      <td>4</td>\n",
       "      <td>general_term</td>\n",
       "      <td>NonOSE_AE</td>\n",
       "      <td>Died in sleep</td>\n",
       "      <td>Death</td>\n",
       "      <td>10011906</td>\n",
       "      <td>General terms or non-specific text such as broad categories (e.g., MedDRA system organ class) used to introdue AEs or text describe an outcome (e.g., death) rather than an AE. These are not of interest.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>1</td>\n",
       "      <td>impavido</td>\n",
       "      <td>4</td>\n",
       "      <td>general_term</td>\n",
       "      <td>NonOSE_AE</td>\n",
       "      <td>Died in sleep</td>\n",
       "      <td>Death</td>\n",
       "      <td>10011906</td>\n",
       "      <td>General terms or non-specific text such as broad categories (e.g., MedDRA system organ class) used to introdue AEs or text describe an outcome (e.g., death) rather than an AE. These are not of interest.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>2</td>\n",
       "      <td>impavido</td>\n",
       "      <td>26</td>\n",
       "      <td>general_term</td>\n",
       "      <td>NonOSE_AE</td>\n",
       "      <td>Disorder gastrointestinal</td>\n",
       "      <td>Gastrointestinal disorder</td>\n",
       "      <td>10017944</td>\n",
       "      <td>General terms or non-specific text such as broad categories (e.g., MedDRA system organ class) used to introdue AEs or text describe an outcome (e.g., death) rather than an AE. These are not of interest.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>3</td>\n",
       "      <td>impavido</td>\n",
       "      <td>17</td>\n",
       "      <td>general_term</td>\n",
       "      <td>NonOSE_AE</td>\n",
       "      <td>Ill-defined disorder</td>\n",
       "      <td>Ill-defined disorder</td>\n",
       "      <td>10061520</td>\n",
       "      <td>General terms or non-specific text such as broad categories (e.g., MedDRA system organ class) used to introdue AEs or text describe an outcome (e.g., death) rather than an AE. These are not of interest.</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>4</td>\n",
       "      <td>impavido</td>\n",
       "      <td>34</td>\n",
       "      <td>general_term</td>\n",
       "      <td>NonOSE_AE</td>\n",
       "      <td>Metabolic disorder</td>\n",
       "      <td>Metabolic disorder</td>\n",
       "      <td>10058097</td>\n",
       "      <td>General terms or non-specific text such as broad categories (e.g., MedDRA system organ class) used to introdue AEs or text describe an outcome (e.g., death) rather than an AE. These are not of interest.</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "   Unnamed: 0      file len        reason       type                 meddra_llt                  meddra_pt  meddra_pt_id                                                                                                                                                                                                 description\n",
       "0           0  impavido   4  general_term  NonOSE_AE              Died in sleep                      Death      10011906  General terms or non-specific text such as broad categories (e.g., MedDRA system organ class) used to introdue AEs or text describe an outcome (e.g., death) rather than an AE. These are not of interest.\n",
       "1           1  impavido   4  general_term  NonOSE_AE              Died in sleep                      Death      10011906  General terms or non-specific text such as broad categories (e.g., MedDRA system organ class) used to introdue AEs or text describe an outcome (e.g., death) rather than an AE. These are not of interest.\n",
       "2           2  impavido  26  general_term  NonOSE_AE  Disorder gastrointestinal  Gastrointestinal disorder      10017944  General terms or non-specific text such as broad categories (e.g., MedDRA system organ class) used to introdue AEs or text describe an outcome (e.g., death) rather than an AE. These are not of interest.\n",
       "3           3  impavido  17  general_term  NonOSE_AE       Ill-defined disorder       Ill-defined disorder      10061520  General terms or non-specific text such as broad categories (e.g., MedDRA system organ class) used to introdue AEs or text describe an outcome (e.g., death) rather than an AE. These are not of interest.\n",
       "4           4  impavido  34  general_term  NonOSE_AE         Metabolic disorder         Metabolic disorder      10058097  General terms or non-specific text such as broad categories (e.g., MedDRA system organ class) used to introdue AEs or text describe an outcome (e.g., death) rather than an AE. These are not of interest."
      ]
     },
     "execution_count": 2,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "labels_and_info = pd.read_csv(\"./data/labels_and_info.csv\")\n",
    "labels_and_info.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>type</th>\n",
       "      <th>reason</th>\n",
       "      <th>description</th>\n",
       "      <th>counts</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NonOSE_AE</td>\n",
       "      <td>AE_only_as_instruction</td>\n",
       "      <td>AES mentioned in instructions are often mentioned in a hypothetical context, with instructions for what to do if they develop. These AES are not of interest.</td>\n",
       "      <td>3384</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>NonOSE_AE</td>\n",
       "      <td>general_term</td>\n",
       "      <td>General terms or non-specific text such as broad categories (e.g., MedDRA system organ class) used to introdue AEs or text describe an outcome (e.g., death) rather than an AE. These are not of interest.</td>\n",
       "      <td>2122</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>Not_AE_Candidate</td>\n",
       "      <td>preexisting_condition_or_risk_factor</td>\n",
       "      <td>Mentions that describe a condition that developed prior to applying the medication of interest, or condition that increases the likelihood of developing a disease or injury. These mentions are not AEs.</td>\n",
       "      <td>1882</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>Not_AE_Candidate</td>\n",
       "      <td>indication</td>\n",
       "      <td>A clinical symptom or circumstance for which the use of the drug of interest would be appropriate. These mentions are not AEs.</td>\n",
       "      <td>1434</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>NonOSE_AE</td>\n",
       "      <td>manifestation_or_complication</td>\n",
       "      <td>Text describing signs, symptoms, or changes in lab resuts related to the manifestations of an AE and the sequelae of an AE are not of interest.</td>\n",
       "      <td>1144</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NonOSE_AE</td>\n",
       "      <td>AE_from_drug_interaction</td>\n",
       "      <td>AEs that result from drug-drug interaction or co-administration are not of interest.</td>\n",
       "      <td>328</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>NonOSE_AE</td>\n",
       "      <td>AE_rate_lteq_placebo</td>\n",
       "      <td>Aes with incidence rate equal to or lower than placebo are not of interest.</td>\n",
       "      <td>306</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>NonOSE_AE</td>\n",
       "      <td>negation</td>\n",
       "      <td>AE whose presence or occurrence is negated or denied. These AEs are not of interst.</td>\n",
       "      <td>245</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NonOSE_AE</td>\n",
       "      <td>AE_animal</td>\n",
       "      <td>AEs observed in animal data are not of interest.</td>\n",
       "      <td>241</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>NonOSE_AE</td>\n",
       "      <td>OD_or_withdrawal</td>\n",
       "      <td>AE associated with discontinuing a medication or taking more than the prescribed amount. Drug overdoes and withdrawal do not generally occur when a drug is used as indicated. Additionally, in the context of pharmacovigilance, identifying AEs associated with the drug when used as indicated is the highest priority. These AEs are not of interest.</td>\n",
       "      <td>206</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NonOSE_AE</td>\n",
       "      <td>AE_from_off_label</td>\n",
       "      <td>AES associated with off-label or unapproved drug use are not of interest.</td>\n",
       "      <td>87</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>Not_AE_Candidate</td>\n",
       "      <td>contraindication</td>\n",
       "      <td>A clinical symptom, circumstance, or condition for which the use of the drug of interest would be inappropriate. These mentions are not AEs.</td>\n",
       "      <td>61</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NonOSE_AE</td>\n",
       "      <td>AE_for_another_drug_in_class</td>\n",
       "      <td>AE is related to a class effect but the label specifically states that the AE has not been reported or associated with the drug of interest or that the AE was only reported in another drug in the class to which the drug of interest belongs. These Aes are not of interest.</td>\n",
       "      <td>55</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>Not_AE_Candidate</td>\n",
       "      <td>other</td>\n",
       "      <td>A reason other than the specific reasons listed that the mention is not actually an AE.</td>\n",
       "      <td>19</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>NonOSE_AE</td>\n",
       "      <td>other</td>\n",
       "      <td>A reason for disinterest other than the specific reasons listed.</td>\n",
       "      <td>6</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                type                                reason                                                                                                                                                                                                                                                                                                                                                description  counts\n",
       "4          NonOSE_AE                AE_only_as_instruction                                                                                                                                                                                              AES mentioned in instructions are often mentioned in a hypothetical context, with instructions for what to do if they develop. These AES are not of interest.    3384\n",
       "7          NonOSE_AE                          general_term                                                                                                                                                 General terms or non-specific text such as broad categories (e.g., MedDRA system organ class) used to introdue AEs or text describe an outcome (e.g., death) rather than an AE. These are not of interest.    2122\n",
       "14  Not_AE_Candidate  preexisting_condition_or_risk_factor                                                                                                                                                  Mentions that describe a condition that developed prior to applying the medication of interest, or condition that increases the likelihood of developing a disease or injury. These mentions are not AEs.    1882\n",
       "12  Not_AE_Candidate                            indication                                                                                                                                                                                                                             A clinical symptom or circumstance for which the use of the drug of interest would be appropriate. These mentions are not AEs.    1434\n",
       "8          NonOSE_AE         manifestation_or_complication                                                                                                                                                                                                            Text describing signs, symptoms, or changes in lab resuts related to the manifestations of an AE and the sequelae of an AE are not of interest.    1144\n",
       "2          NonOSE_AE              AE_from_drug_interaction                                                                                                                                                                                                                                                                       AEs that result from drug-drug interaction or co-administration are not of interest.     328\n",
       "5          NonOSE_AE                  AE_rate_lteq_placebo                                                                                                                                                                                                                                                                                Aes with incidence rate equal to or lower than placebo are not of interest.     306\n",
       "9          NonOSE_AE                              negation                                                                                                                                                                                                                                                                        AE whose presence or occurrence is negated or denied. These AEs are not of interst.     245\n",
       "0          NonOSE_AE                             AE_animal                                                                                                                                                                                                                                                                                                           AEs observed in animal data are not of interest.     241\n",
       "6          NonOSE_AE                      OD_or_withdrawal  AE associated with discontinuing a medication or taking more than the prescribed amount. Drug overdoes and withdrawal do not generally occur when a drug is used as indicated. Additionally, in the context of pharmacovigilance, identifying AEs associated with the drug when used as indicated is the highest priority. These AEs are not of interest.     206\n",
       "3          NonOSE_AE                     AE_from_off_label                                                                                                                                                                                                                                                                                  AES associated with off-label or unapproved drug use are not of interest.      87\n",
       "11  Not_AE_Candidate                      contraindication                                                                                                                                                                                                              A clinical symptom, circumstance, or condition for which the use of the drug of interest would be inappropriate. These mentions are not AEs.Â       61\n",
       "1          NonOSE_AE          AE_for_another_drug_in_class                                                                            AE is related to a class effect but the label specifically states that the AE has not been reported or associated with the drug of interest or that the AE was only reported in another drug in the class to which the drug of interest belongs. These Aes are not of interest.      55\n",
       "13  Not_AE_Candidate                                 other                                                                                                                                                                                                                                                                    A reason other than the specific reasons listed that the mention is not actually an AE.      19\n",
       "10         NonOSE_AE                                 other                                                                                                                                                                                                                                                                                           A reason for disinterest other than the specific reasons listed.       6"
      ]
     },
     "execution_count": 3,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "reason_counts = pd.DataFrame(labels_and_info.groupby(['type','reason', 'description'])['type','reason', 'description'].size().reset_index(name='counts')).sort_values(['counts'], ascending=False)\n",
    "reason_counts"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>file</th>\n",
       "      <th>sent_id</th>\n",
       "      <th>sent_start</th>\n",
       "      <th>sent_end</th>\n",
       "      <th>sentence</th>\n",
       "      <th>nonoseaeaeonlyasinstruction</th>\n",
       "      <th>nonoseaegeneralterm</th>\n",
       "      <th>notaecandidatepreexistingconditionorriskfactor</th>\n",
       "      <th>notaecandidateindication</th>\n",
       "      <th>nonoseaemanifestationorcomplication</th>\n",
       "      <th>nonoseaeaefromdruginteraction</th>\n",
       "      <th>nonoseaeaeratelteqplacebo</th>\n",
       "      <th>nonoseaenegation</th>\n",
       "      <th>nonoseaeaeanimal</th>\n",
       "      <th>nonoseaeodorwithdrawal</th>\n",
       "      <th>nonoseaeaefromofflabel</th>\n",
       "      <th>notaecandidatecontraindication</th>\n",
       "      <th>nonoseaeaeforanotherdruginclass</th>\n",
       "      <th>notaecandidateother</th>\n",
       "      <th>nonoseaeother</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>carboplatin</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>49</td>\n",
       "      <td>['  ADVERSE REACTIONS\\n', '\\n', '  For a comparison of toxicities when carboplatin or cisplatin was given in combination with cyclophosphamide, see    CLINICAL STUDIES, Use with Cyclophosphamide for Initial Treatment of  notaecandidateindication  Comparative Toxicity  .</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>carboplatin</td>\n",
       "      <td>1</td>\n",
       "      <td>49</td>\n",
       "      <td>155</td>\n",
       "      <td>\\n', '\\n', ' ADVERSE EXPERIENCES IN PATIENTS WITH OVARIAN CANCER \\n', '                                                    First Line    Combination Therapy   [note: Use with Cyclophosphamide for Initial Treatment of  notaecandidateindication  Data are based on the experience of 393 patients with  notaecandidateindication (regardless of baseline status) who received initial combination therapy with carboplatin and cyclophosphamide in two randomized controlled studies conducted by SWOG and NCIC (see CLINICAL STUDIES).Combination with cyclophosphamide as well as duration of treatment may be responsible for the differences that can be noted in the adverse experience table.]</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>carboplatin</td>\n",
       "      <td>2</td>\n",
       "      <td>155</td>\n",
       "      <td>157</td>\n",
       "      <td>Percent</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>carboplatin</td>\n",
       "      <td>3</td>\n",
       "      <td>157</td>\n",
       "      <td>163</td>\n",
       "      <td>Second Line    Single Agent</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>carboplatin</td>\n",
       "      <td>4</td>\n",
       "      <td>163</td>\n",
       "      <td>165</td>\n",
       "      <td>Therapy</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "          file  sent_id  sent_start  sent_end                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    sentence  nonoseaeaeonlyasinstruction  nonoseaegeneralterm  notaecandidatepreexistingconditionorriskfactor  notaecandidateindication  nonoseaemanifestationorcomplication  nonoseaeaefromdruginteraction  nonoseaeaeratelteqplacebo  nonoseaenegation  nonoseaeaeanimal  nonoseaeodorwithdrawal  nonoseaeaefromofflabel  notaecandidatecontraindication  nonoseaeaeforanotherdruginclass  notaecandidateother  nonoseaeother\n",
       "0  carboplatin        0           0        49                                                                                                                                                                                                                                                                                                                                                                                                                            ['  ADVERSE REACTIONS\\n', '\\n', '  For a comparison of toxicities when carboplatin or cisplatin was given in combination with cyclophosphamide, see    CLINICAL STUDIES, Use with Cyclophosphamide for Initial Treatment of  notaecandidateindication  Comparative Toxicity  .                              0                    0                                               0                         1                                    0                              0                          0                 0                 0                       0                       0                               0                                0                    0              0\n",
       "1  carboplatin        1          49       155  \\n', '\\n', ' ADVERSE EXPERIENCES IN PATIENTS WITH OVARIAN CANCER \\n', '                                                    First Line    Combination Therapy   [note: Use with Cyclophosphamide for Initial Treatment of  notaecandidateindication  Data are based on the experience of 393 patients with  notaecandidateindication (regardless of baseline status) who received initial combination therapy with carboplatin and cyclophosphamide in two randomized controlled studies conducted by SWOG and NCIC (see CLINICAL STUDIES).Combination with cyclophosphamide as well as duration of treatment may be responsible for the differences that can be noted in the adverse experience table.]                               0                    0                                               0                         1                                    0                              0                          0                 0                 0                       0                       0                               0                                0                    0              0\n",
       "2  carboplatin        2         155       157                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Percent                                  0                    0                                               0                         0                                    0                              0                          0                 0                 0                       0                       0                               0                                0                    0              0\n",
       "3  carboplatin        3         157       163                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             Second Line    Single Agent                                0                    0                                               0                         0                                    0                              0                          0                 0                 0                       0                       0                               0                                0                    0              0\n",
       "4  carboplatin        4         163       165                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Therapy                               0                    0                                               0                         0                                    0                              0                          0                 0                 0                       0                       0                               0                                0                    0              0"
      ]
     },
     "execution_count": 4,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "feat_mat = pd.read_csv(\"./data/feature_matrix.csv\", header=0, index_col=0)\n",
    "feat_mat.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [],
   "source": [
    "def filter_feature_matrix(list_of_reasons, f_matrix, keep_only_true=True, replace_reason_name_w_noun=False, reason_replace_dict=None):\n",
    "    \n",
    "    '''\n",
    "    We can use this function to subset the feature matrix by ground-truth label(s) and/or to keep only rows where the value for >=1 of the labels we've selected is TRUE\n",
    "    '''\n",
    "    \n",
    "    cols = [\"file\", \"sent_id\", \"sent_start\", \"sent_end\", \"sentence\"]\n",
    "    cols += list_of_reasons\n",
    "    \n",
    "    temp = f_matrix.copy()\n",
    "    \n",
    "    if replace_reason_name_w_noun and reason_replace_dict is not None:\n",
    "\n",
    "        for r in list_of_reasons:\n",
    "        \n",
    "            temp.loc[:, \"sentence\"] = [\"{}\".format(sent).replace(r, reason_replace_dict[r]) for sent in temp.loc[:, \"sentence\"]]\n",
    "    \n",
    "    # For initial review, it can be helpful to only review the positive instances\n",
    "    if keep_only_true:\n",
    "        \n",
    "        subset_df = temp.loc[:, cols]\n",
    "        subset_df['row_sum'] = temp.loc[:, list_of_reasons].sum(axis=1)  \n",
    "        \n",
    "        return subset_df[subset_df[\"row_sum\"] >= 1]\n",
    "    \n",
    "    # But it's important not to forget the sentences w/ FALSE values for the subset of labels we've specified \n",
    "    else:\n",
    "        return temp.loc[:, [cols]]\n",
    "    \n",
    "def generate_ngrams(f_mat, r_list, n=3, filter_punc=True, filter_ngrams_by_r=True):\n",
    "    \n",
    "    ngram_df = pd.DataFrame()\n",
    "    \n",
    "    cols = [\"drug_name\", \"n\"]\n",
    "    \n",
    "    for i in range(n):\n",
    "        cols.append(\"token_{}\".format(i))\n",
    "\n",
    "    counter = 0\n",
    "    \n",
    "    for i, row in f_mat.iterrows():\n",
    "        drug_name = row['file'].lower()\n",
    "        doc = textacy.Doc(textacy.preprocess_text(u'{}'.format(row['sentence'].lower())), lang='en')\n",
    "        ngrams = textacy.extract.ngrams(doc, n, filter_stops=False, filter_punct=filter_punc, filter_nums=False)\n",
    "\n",
    "        if  filter_ngrams_by_r:\n",
    "            \n",
    "            #for x in ngrams:\n",
    "                #print(x, any(reason in str(x) for reason in r_list))\n",
    "        \n",
    "            ngrams = [x for x in ngrams if any(reason in str(x).lower() for reason in r_list)]\n",
    "        \n",
    "        for ngram in ngrams:\n",
    "                ngram_df.loc[counter, \"drug_name\"] = drug_name\n",
    "                ngram_df.loc[counter, \"n\"] = n\n",
    "                ngram_df.loc[counter, \"reason\"] = None\n",
    "                \n",
    "                for i in range(n):\n",
    "                    ngram_df.loc[counter, \"token_{}\".format(i)] = ngram[i] if not None else \" \"\n",
    "                    \n",
    "                    if u'{}'.format(ngram[i]).strip() in r_list:\n",
    "                        #print(ngram[i])\n",
    "                        ngram_df.loc[counter, 'reason'] = str(ngram[i])\n",
    "                counter += 1\n",
    "        \n",
    "    return ngram_df\n",
    "\n",
    "def find_ngrams_with_label_not_in_initial_position(ngramdf, r_list):\n",
    "    \n",
    "    out = pd.DataFrame()\n",
    "    \n",
    "    cols = [\"{}_in_pos_0\".format(r) for r in r_list]\n",
    "\n",
    "    for r in r_list:\n",
    "        \n",
    "        ngramdf[\"{}_in_pos_0\".format(r)] = 0\n",
    "        \n",
    "        for i, row in ngramdf.iterrows():\n",
    "\n",
    "            if row['token_0'].text == r:\n",
    "                ngramdf.loc[i, \"{}_in_pos_0\".format(r)] = 1\n",
    "                \n",
    "    \n",
    "    ngramdf['row_sum'] = ngramdf.loc[:, cols].sum(axis=1)\n",
    "    print(\"Min row sum= \", ngramdf['row_sum'].min())\n",
    "    return ngramdf[ngramdf['row_sum'] == 0]\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "(86, 8)\n"
     ]
    }
   ],
   "source": [
    "# We have to consider contraindication here again because pregnancy mentions show up under that type_reason. \n",
    "labels_b = [\"notaecandidatecontraindication\", \"nonoseaeodorwithdrawal\"] \n",
    "subdf_b = filter_feature_matrix(labels_b, feat_mat, keep_only_true=True)\n",
    "print(subdf_b.shape)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>file</th>\n",
       "      <th>sent_id</th>\n",
       "      <th>sent_start</th>\n",
       "      <th>sent_end</th>\n",
       "      <th>sentence</th>\n",
       "      <th>notaecandidatecontraindication</th>\n",
       "      <th>nonoseaeodorwithdrawal</th>\n",
       "      <th>row_sum</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>43</th>\n",
       "      <td>valium</td>\n",
       "      <td>43</td>\n",
       "      <td>2398</td>\n",
       "      <td>2464</td>\n",
       "      <td>Abrupt withdrawal of Valium in such cases may also be associated with a temporary increase in the frequency and/or severity of  nonoseaeodorwithdrawal \\n', '\\n', '    Pregnancy\\n', '\\n', '  An increased risk of  oselabeledaeclasseffect  and other  oselabeledaeclasseffect associated with the use of benzodiazepine drugs during  notaecandidatepreexistingconditionorriskfactor has been suggested.</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>68</th>\n",
       "      <td>cytoxan</td>\n",
       "      <td>68</td>\n",
       "      <td>2219</td>\n",
       "      <td>2266</td>\n",
       "      <td>nonoseaeaeonlyasinstruction can be  nonoseaegeneralterm   oselabeledaefromdruguse can occur with short-term or long-term use of cyclophosphamide.\\n', '\\n', ' Before starting treatment, exclude or correct any  notaecandidatecontraindication [see  Contraindications (4)  ].</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>79</th>\n",
       "      <td>anoro</td>\n",
       "      <td>79</td>\n",
       "      <td>2355</td>\n",
       "      <td>2451</td>\n",
       "      <td>Increasing the daily dose of ANORO ELLIPTA beyond the recommended dose is not appropriate in this situation.\\n\", '\\n', '\\n', '\\n', '    5.3 Excessive Use of ANORO ELLIPTA and Use With Other Long-Acting Beta2-Agonists\\n', '\\n', '\\n', '\\n', '  ANORO ELLIPTA should not be used more often than recommended, at higher doses than recommended, or in conjunction with other medicines containing LABA, as an  nonoseaeodorwithdrawal may result.</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>80</th>\n",
       "      <td>anoro</td>\n",
       "      <td>80</td>\n",
       "      <td>2451</td>\n",
       "      <td>2470</td>\n",
       "      <td>Clinically significant  nonoseaeodorwithdrawal and fatalities have been reported in association with excessive use of inhaled sympathomimetic drugs.</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>lioresal</td>\n",
       "      <td>3</td>\n",
       "      <td>199</td>\n",
       "      <td>242</td>\n",
       "      <td>Eleven patients who developed  nonoseaeodorwithdrawal secondary to  nonoseaeodorwithdrawal had their treatment temporarily suspended, but all were subsequently re-started and were not, therefore, considered to be true discontinuations.\\n', '\\n', '    nonoseaegeneralterm</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "        file  sent_id  sent_start  sent_end                                                                                                                                                                                                                                                                                                                                                                                                                                             sentence  notaecandidatecontraindication  nonoseaeodorwithdrawal  row_sum\n",
       "43    valium       43        2398      2464                                           Abrupt withdrawal of Valium in such cases may also be associated with a temporary increase in the frequency and/or severity of  nonoseaeodorwithdrawal \\n', '\\n', '    Pregnancy\\n', '\\n', '  An increased risk of  oselabeledaeclasseffect  and other  oselabeledaeclasseffect associated with the use of benzodiazepine drugs during  notaecandidatepreexistingconditionorriskfactor has been suggested.                               0                       1        1\n",
       "68   cytoxan       68        2219      2266                                                                                                                                                                      nonoseaeaeonlyasinstruction can be  nonoseaegeneralterm   oselabeledaefromdruguse can occur with short-term or long-term use of cyclophosphamide.\\n', '\\n', ' Before starting treatment, exclude or correct any  notaecandidatecontraindication [see  Contraindications (4)  ].                               1                       0        1\n",
       "79     anoro       79        2355      2451  Increasing the daily dose of ANORO ELLIPTA beyond the recommended dose is not appropriate in this situation.\\n\", '\\n', '\\n', '\\n', '    5.3 Excessive Use of ANORO ELLIPTA and Use With Other Long-Acting Beta2-Agonists\\n', '\\n', '\\n', '\\n', '  ANORO ELLIPTA should not be used more often than recommended, at higher doses than recommended, or in conjunction with other medicines containing LABA, as an  nonoseaeodorwithdrawal may result.                               0                       1        1\n",
       "80     anoro       80        2451      2470                                                                                                                                                                                                                                                                                                 Clinically significant  nonoseaeodorwithdrawal and fatalities have been reported in association with excessive use of inhaled sympathomimetic drugs.                               0                       1        1\n",
       "3   lioresal        3         199       242                                                                                                                                                                       Eleven patients who developed  nonoseaeodorwithdrawal secondary to  nonoseaeodorwithdrawal had their treatment temporarily suspended, but all were subsequently re-started and were not, therefore, considered to be true discontinuations.\\n', '\\n', '    nonoseaegeneralterm                               0                       1        1"
      ]
     },
     "execution_count": 9,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "subdf_b.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(425, 8)"
      ]
     },
     "execution_count": 17,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "ngramdf_b = generate_ngrams(subdf_b, labels_b, n=5, filter_punc=True, filter_ngrams_by_r=True)\n",
    "ngramdf_b.shape"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>drug_name</th>\n",
       "      <th>n</th>\n",
       "      <th>reason</th>\n",
       "      <th>token_0</th>\n",
       "      <th>token_1</th>\n",
       "      <th>token_2</th>\n",
       "      <th>token_3</th>\n",
       "      <th>token_4</th>\n",
       "      <th>notaecandidatecontraindication_in_pos_0</th>\n",
       "      <th>nonoseaeodorwithdrawal_in_pos_0</th>\n",
       "      <th>row_sum</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>valium</td>\n",
       "      <td>5.0</td>\n",
       "      <td>nonoseaeodorwithdrawal</td>\n",
       "      <td>frequency</td>\n",
       "      <td>and/or</td>\n",
       "      <td>severity</td>\n",
       "      <td>of</td>\n",
       "      <td>nonoseaeodorwithdrawal</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>valium</td>\n",
       "      <td>5.0</td>\n",
       "      <td>nonoseaeodorwithdrawal</td>\n",
       "      <td>and/or</td>\n",
       "      <td>severity</td>\n",
       "      <td>of</td>\n",
       "      <td>nonoseaeodorwithdrawal</td>\n",
       "      <td>\\n</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>cytoxan</td>\n",
       "      <td>5.0</td>\n",
       "      <td>notaecandidatecontraindication</td>\n",
       "      <td>exclude</td>\n",
       "      <td>or</td>\n",
       "      <td>correct</td>\n",
       "      <td>any</td>\n",
       "      <td>notaecandidatecontraindication</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>anoro</td>\n",
       "      <td>5.0</td>\n",
       "      <td>nonoseaeodorwithdrawal</td>\n",
       "      <td>as</td>\n",
       "      <td>an</td>\n",
       "      <td>nonoseaeodorwithdrawal</td>\n",
       "      <td>may</td>\n",
       "      <td>result</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>anoro</td>\n",
       "      <td>5.0</td>\n",
       "      <td>nonoseaeodorwithdrawal</td>\n",
       "      <td>clinically</td>\n",
       "      <td>significant</td>\n",
       "      <td>nonoseaeodorwithdrawal</td>\n",
       "      <td>and</td>\n",
       "      <td>fatalities</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "  drug_name    n                          reason     token_0      token_1                 token_2                 token_3                         token_4  notaecandidatecontraindication_in_pos_0  nonoseaeodorwithdrawal_in_pos_0  row_sum\n",
       "0    valium  5.0          nonoseaeodorwithdrawal   frequency       and/or                severity                      of          nonoseaeodorwithdrawal                                        0                                0        0\n",
       "1    valium  5.0          nonoseaeodorwithdrawal      and/or     severity                      of  nonoseaeodorwithdrawal                              \\n                                        0                                0        0\n",
       "2   cytoxan  5.0  notaecandidatecontraindication     exclude           or                 correct                     any  notaecandidatecontraindication                                        0                                0        0\n",
       "3     anoro  5.0          nonoseaeodorwithdrawal          as           an  nonoseaeodorwithdrawal                     may                          result                                        0                                0        0\n",
       "4     anoro  5.0          nonoseaeodorwithdrawal  clinically  significant  nonoseaeodorwithdrawal                     and                      fatalities                                        0                                0        0"
      ]
     },
     "execution_count": 19,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "ngramdf_b.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Min row sum=  0\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "(262, 11)"
      ]
     },
     "execution_count": 18,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Looking at the n-gram results for these labels can help us build upon our existing knowledge of the world \n",
    "# to develop an initial set of terms, and/or patterns\n",
    "ngramdf_b_non_token_zero = find_ngrams_with_label_not_in_initial_position(ngramdf_b, labels_b)\n",
    "ngramdf_b_non_token_zero.shape"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>drug_name</th>\n",
       "      <th>n</th>\n",
       "      <th>reason</th>\n",
       "      <th>token_0</th>\n",
       "      <th>token_1</th>\n",
       "      <th>token_2</th>\n",
       "      <th>token_3</th>\n",
       "      <th>token_4</th>\n",
       "      <th>notaecandidatecontraindication_in_pos_0</th>\n",
       "      <th>nonoseaeodorwithdrawal_in_pos_0</th>\n",
       "      <th>row_sum</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>valium</td>\n",
       "      <td>5.0</td>\n",
       "      <td>nonoseaeodorwithdrawal</td>\n",
       "      <td>frequency</td>\n",
       "      <td>and/or</td>\n",
       "      <td>severity</td>\n",
       "      <td>of</td>\n",
       "      <td>nonoseaeodorwithdrawal</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>valium</td>\n",
       "      <td>5.0</td>\n",
       "      <td>nonoseaeodorwithdrawal</td>\n",
       "      <td>and/or</td>\n",
       "      <td>severity</td>\n",
       "      <td>of</td>\n",
       "      <td>nonoseaeodorwithdrawal</td>\n",
       "      <td>\\n</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>cytoxan</td>\n",
       "      <td>5.0</td>\n",
       "      <td>notaecandidatecontraindication</td>\n",
       "      <td>exclude</td>\n",
       "      <td>or</td>\n",
       "      <td>correct</td>\n",
       "      <td>any</td>\n",
       "      <td>notaecandidatecontraindication</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>anoro</td>\n",
       "      <td>5.0</td>\n",
       "      <td>nonoseaeodorwithdrawal</td>\n",
       "      <td>as</td>\n",
       "      <td>an</td>\n",
       "      <td>nonoseaeodorwithdrawal</td>\n",
       "      <td>may</td>\n",
       "      <td>result</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>anoro</td>\n",
       "      <td>5.0</td>\n",
       "      <td>nonoseaeodorwithdrawal</td>\n",
       "      <td>clinically</td>\n",
       "      <td>significant</td>\n",
       "      <td>nonoseaeodorwithdrawal</td>\n",
       "      <td>and</td>\n",
       "      <td>fatalities</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "  drug_name    n                          reason     token_0      token_1                 token_2                 token_3                         token_4  notaecandidatecontraindication_in_pos_0  nonoseaeodorwithdrawal_in_pos_0  row_sum\n",
       "0    valium  5.0          nonoseaeodorwithdrawal   frequency       and/or                severity                      of          nonoseaeodorwithdrawal                                        0                                0        0\n",
       "1    valium  5.0          nonoseaeodorwithdrawal      and/or     severity                      of  nonoseaeodorwithdrawal                              \\n                                        0                                0        0\n",
       "2   cytoxan  5.0  notaecandidatecontraindication     exclude           or                 correct                     any  notaecandidatecontraindication                                        0                                0        0\n",
       "3     anoro  5.0          nonoseaeodorwithdrawal          as           an  nonoseaeodorwithdrawal                     may                          result                                        0                                0        0\n",
       "4     anoro  5.0          nonoseaeodorwithdrawal  clinically  significant  nonoseaeodorwithdrawal                     and                      fatalities                                        0                                0        0"
      ]
     },
     "execution_count": 20,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "ngramdf_b_non_token_zero.head()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "## NOTES HERE\n",
    "\n",
    "* temporality - suddeness\n",
    "* chemical compounds\n",
    "\n",
    "## NEW THINGS START HERE"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### Detecting Overdose and Withdrawal"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(43, 8)"
      ]
     },
     "execution_count": 22,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5977697/\n",
    "\n",
    "overdose_df =  subdf_b[subdf_b['sentence'].str.contains(\"nonoseaeodorwithdrawal\")]\n",
    "overdose_df.shape"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 62,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>file</th>\n",
       "      <th>sent_id</th>\n",
       "      <th>sent_start</th>\n",
       "      <th>sent_end</th>\n",
       "      <th>sentence</th>\n",
       "      <th>notaecandidatecontraindication</th>\n",
       "      <th>nonoseaeodorwithdrawal</th>\n",
       "      <th>row_sum</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>43</th>\n",
       "      <td>valium</td>\n",
       "      <td>43</td>\n",
       "      <td>2398</td>\n",
       "      <td>2464</td>\n",
       "      <td>Abrupt withdrawal of Valium in such cases may also be associated with a temporary increase in the frequency and/or severity of  nonoseaeodorwithdrawal \\n', '\\n', '    Pregnancy\\n', '\\n', '  An increased risk of  oselabeledaeclasseffect  and other  oselabeledaeclasseffect associated with the use of benzodiazepine drugs during  notaecandidatepreexistingconditionorriskfactor has been suggested.</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>79</th>\n",
       "      <td>anoro</td>\n",
       "      <td>79</td>\n",
       "      <td>2355</td>\n",
       "      <td>2451</td>\n",
       "      <td>Increasing the daily dose of ANORO ELLIPTA beyond the recommended dose is not appropriate in this situation.\\n\", '\\n', '\\n', '\\n', '    5.3 Excessive Use of ANORO ELLIPTA and Use With Other Long-Acting Beta2-Agonists\\n', '\\n', '\\n', '\\n', '  ANORO ELLIPTA should not be used more often than recommended, at higher doses than recommended, or in conjunction with other medicines containing LABA, as an  nonoseaeodorwithdrawal may result.</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>80</th>\n",
       "      <td>anoro</td>\n",
       "      <td>80</td>\n",
       "      <td>2451</td>\n",
       "      <td>2470</td>\n",
       "      <td>Clinically significant  nonoseaeodorwithdrawal and fatalities have been reported in association with excessive use of inhaled sympathomimetic drugs.</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>lioresal</td>\n",
       "      <td>3</td>\n",
       "      <td>199</td>\n",
       "      <td>242</td>\n",
       "      <td>Eleven patients who developed  nonoseaeodorwithdrawal secondary to  nonoseaeodorwithdrawal had their treatment temporarily suspended, but all were subsequently re-started and were not, therefore, considered to be true discontinuations.\\n', '\\n', '    nonoseaegeneralterm</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>243</th>\n",
       "      <td>lioresal</td>\n",
       "      <td>243</td>\n",
       "      <td>3117</td>\n",
       "      <td>3137</td>\n",
       "      <td>nonoseaeodorwithdrawal has been reported following baclofen  nonoseaeaeonlyasinstruction \\n', '\\n', '    BOXED WARNING:</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>244</th>\n",
       "      <td>lioresal</td>\n",
       "      <td>244</td>\n",
       "      <td>3137</td>\n",
       "      <td>3221</td>\n",
       "      <td>\\n', '\\n', '   oselabeledaefromdruguse  regardless of the cause, has resulted in sequelae that include  nonoseaeodorwithdrawal   nonoseaeodorwithdrawal   nonoseaeodorwithdrawal  and  nonoseaeodorwithdrawal  that in rare cases has advanced to  nonoseaeodorwithdrawal   nonoseaeodorwithdrawal and  nonoseaegeneralterm  \\n', '\\n', ' Prevention of abrupt discontinuation of intrathecal baclofen requires careful attention to programming and monitoring of the infusion system, refill scheduling and procedures, and pump alarms.</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>250</th>\n",
       "      <td>lioresal</td>\n",
       "      <td>250</td>\n",
       "      <td>3534</td>\n",
       "      <td>3552</td>\n",
       "      <td>Subcutaneous injection may result in symptoms of a systemic  nonoseaeodorwithdrawal or early depletion of the reservoir.</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>253</th>\n",
       "      <td>lioresal</td>\n",
       "      <td>253</td>\n",
       "      <td>3660</td>\n",
       "      <td>3823</td>\n",
       "      <td>oselabeledaemedicationerror through the catheter access port may cause a life-threatening  nonoseaeodorwithdrawal   \\n', '\\n', '    Additional considerations pertaining to dosage adjustment\\n', '\\n', '  It may be important to titrate the dose to maintain some degree of muscle tone and allow occasional  nonoseaeaeonlyasinstruction to: 1) help support circulatory function, 2) possibly prevent the formation of  nonoseaeaeonlyasinstruction  3) optimize activities of daily living and ease of care.\\n', '\\n', ' Except in  nonoseaeaeonlyasinstruction related emergencies, the dose of LIORESAL INTRATHECAL should ordinarily be reduced slowly if the drug is discontinued for any reason.\\n', '\\n', ' An attempt should be made to discontinue concomitant oral antispasticity medication to avoid possible  nonoseaeaeonlyasinstruction or adverse drug interactions, either prior to screening or following implant and initiation of chronic LIORESAL INTRATHECAL infusion.</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>262</th>\n",
       "      <td>lioresal</td>\n",
       "      <td>262</td>\n",
       "      <td>4075</td>\n",
       "      <td>4353</td>\n",
       "      <td>In some cases, performance of an imaging procedure may be appropriate to confirm or rule-out the diagnosis of an  nonoseaeaeonlyasinstruction \\n', '\\n', '    Precautions in special patient populations\\n', '\\n', '  Careful dose titration of LIORESAL INTRATHECAL is needed when  nonoseaeaeonlyasinstruction is necessary to sustain upright posture and balance in locomotion or whenever  nonoseaeaeonlyasinstruction is used to obtain optimal function and care.\\n', '\\n', ' Patients suffering from  notaecandidatepreexistingconditionorriskfactor   notaecandidatepreexistingconditionorriskfactor  or  notaecandidatepreexistingconditionorriskfactor should be treated cautiously with LIORESAL INTRATHECAL and kept under careful surveillance, because exacerbations of these conditions have been observed with oral administration.\\n', '\\n', ' LIORESAL INTRATHECAL should be used with caution in patients with a history of  notaecandidatepreexistingconditionorriskfactor  The presence of nociceptive stimuli or abrupt  nonoseaeaeonlyasinstruction of LIORESAL INTRATHECAL (baclofen injection) may cause an  nonoseaeodorwithdrawal \\n', '\\n', ' Because LIORESAL is primarily excreted unchanged by the kidneys, it should be given with caution in patients with  notaecandidatepreexistingconditionorriskfactor and it may be necessary to reduce the dosage.\\n', '\\n', '    LABORATORY TESTS\\n', '\\n', '  No specific laboratory tests are deemed essential for the management of patients on LIORESAL INTRATHECAL.\\n', '\\n', '    DRUG INTERACTIONS\\n', '\\n', '  There is inadequate systematic experience with the use of LIORESAL INTRATHECAL in combination with other medications to predict specific drug-drug interactions.</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>283</th>\n",
       "      <td>lioresal</td>\n",
       "      <td>283</td>\n",
       "      <td>5185</td>\n",
       "      <td>5259</td>\n",
       "      <td>Acute massive  oselabeledaefromdruguse may present as  nonoseaeodorwithdrawal  Less sudden and/or less severe forms of  oselabeledaefromdruguse may present with signs of  nonoseaeodorwithdrawal   nonoseaeodorwithdrawal   nonoseaeodorwithdrawal   nonoseaeodorwithdrawal   nonoseaeodorwithdrawal   nonoseaeodorwithdrawal  rostral progression of  nonoseaeodorwithdrawal and  nonoseaeodorwithdrawal progressing to  nonoseaeodorwithdrawal  Should  nonoseaeaeonlyasinstruction appear likely, the patient should be taken immediately to a hospital for assessment and emptying of the pump reservoir.</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "         file  sent_id  sent_start  sent_end                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          sentence  notaecandidatecontraindication  nonoseaeodorwithdrawal  row_sum\n",
       "43     valium       43        2398      2464                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Abrupt withdrawal of Valium in such cases may also be associated with a temporary increase in the frequency and/or severity of  nonoseaeodorwithdrawal \\n', '\\n', '    Pregnancy\\n', '\\n', '  An increased risk of  oselabeledaeclasseffect  and other  oselabeledaeclasseffect associated with the use of benzodiazepine drugs during  notaecandidatepreexistingconditionorriskfactor has been suggested.                               0                       1        1\n",
       "79      anoro       79        2355      2451                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               Increasing the daily dose of ANORO ELLIPTA beyond the recommended dose is not appropriate in this situation.\\n\", '\\n', '\\n', '\\n', '    5.3 Excessive Use of ANORO ELLIPTA and Use With Other Long-Acting Beta2-Agonists\\n', '\\n', '\\n', '\\n', '  ANORO ELLIPTA should not be used more often than recommended, at higher doses than recommended, or in conjunction with other medicines containing LABA, as an  nonoseaeodorwithdrawal may result.                               0                       1        1\n",
       "80      anoro       80        2451      2470                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Clinically significant  nonoseaeodorwithdrawal and fatalities have been reported in association with excessive use of inhaled sympathomimetic drugs.                               0                       1        1\n",
       "3    lioresal        3         199       242                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Eleven patients who developed  nonoseaeodorwithdrawal secondary to  nonoseaeodorwithdrawal had their treatment temporarily suspended, but all were subsequently re-started and were not, therefore, considered to be true discontinuations.\\n', '\\n', '    nonoseaegeneralterm                               0                       1        1\n",
       "243  lioresal      243        3117      3137                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           nonoseaeodorwithdrawal has been reported following baclofen  nonoseaeaeonlyasinstruction \\n', '\\n', '    BOXED WARNING:                               0                       1        1\n",
       "244  lioresal      244        3137      3221                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        \\n', '\\n', '   oselabeledaefromdruguse  regardless of the cause, has resulted in sequelae that include  nonoseaeodorwithdrawal   nonoseaeodorwithdrawal   nonoseaeodorwithdrawal  and  nonoseaeodorwithdrawal  that in rare cases has advanced to  nonoseaeodorwithdrawal   nonoseaeodorwithdrawal and  nonoseaegeneralterm  \\n', '\\n', ' Prevention of abrupt discontinuation of intrathecal baclofen requires careful attention to programming and monitoring of the infusion system, refill scheduling and procedures, and pump alarms.                               0                       1        1\n",
       "250  lioresal      250        3534      3552                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Subcutaneous injection may result in symptoms of a systemic  nonoseaeodorwithdrawal or early depletion of the reservoir.                               0                       1        1\n",
       "253  lioresal      253        3660      3823                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   oselabeledaemedicationerror through the catheter access port may cause a life-threatening  nonoseaeodorwithdrawal   \\n', '\\n', '    Additional considerations pertaining to dosage adjustment\\n', '\\n', '  It may be important to titrate the dose to maintain some degree of muscle tone and allow occasional  nonoseaeaeonlyasinstruction to: 1) help support circulatory function, 2) possibly prevent the formation of  nonoseaeaeonlyasinstruction  3) optimize activities of daily living and ease of care.\\n', '\\n', ' Except in  nonoseaeaeonlyasinstruction related emergencies, the dose of LIORESAL INTRATHECAL should ordinarily be reduced slowly if the drug is discontinued for any reason.\\n', '\\n', ' An attempt should be made to discontinue concomitant oral antispasticity medication to avoid possible  nonoseaeaeonlyasinstruction or adverse drug interactions, either prior to screening or following implant and initiation of chronic LIORESAL INTRATHECAL infusion.                               0                       1        1\n",
       "262  lioresal      262        4075      4353  In some cases, performance of an imaging procedure may be appropriate to confirm or rule-out the diagnosis of an  nonoseaeaeonlyasinstruction \\n', '\\n', '    Precautions in special patient populations\\n', '\\n', '  Careful dose titration of LIORESAL INTRATHECAL is needed when  nonoseaeaeonlyasinstruction is necessary to sustain upright posture and balance in locomotion or whenever  nonoseaeaeonlyasinstruction is used to obtain optimal function and care.\\n', '\\n', ' Patients suffering from  notaecandidatepreexistingconditionorriskfactor   notaecandidatepreexistingconditionorriskfactor  or  notaecandidatepreexistingconditionorriskfactor should be treated cautiously with LIORESAL INTRATHECAL and kept under careful surveillance, because exacerbations of these conditions have been observed with oral administration.\\n', '\\n', ' LIORESAL INTRATHECAL should be used with caution in patients with a history of  notaecandidatepreexistingconditionorriskfactor  The presence of nociceptive stimuli or abrupt  nonoseaeaeonlyasinstruction of LIORESAL INTRATHECAL (baclofen injection) may cause an  nonoseaeodorwithdrawal \\n', '\\n', ' Because LIORESAL is primarily excreted unchanged by the kidneys, it should be given with caution in patients with  notaecandidatepreexistingconditionorriskfactor and it may be necessary to reduce the dosage.\\n', '\\n', '    LABORATORY TESTS\\n', '\\n', '  No specific laboratory tests are deemed essential for the management of patients on LIORESAL INTRATHECAL.\\n', '\\n', '    DRUG INTERACTIONS\\n', '\\n', '  There is inadequate systematic experience with the use of LIORESAL INTRATHECAL in combination with other medications to predict specific drug-drug interactions.                               0                       1        1\n",
       "283  lioresal      283        5185      5259                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Acute massive  oselabeledaefromdruguse may present as  nonoseaeodorwithdrawal  Less sudden and/or less severe forms of  oselabeledaefromdruguse may present with signs of  nonoseaeodorwithdrawal   nonoseaeodorwithdrawal   nonoseaeodorwithdrawal   nonoseaeodorwithdrawal   nonoseaeodorwithdrawal   nonoseaeodorwithdrawal  rostral progression of  nonoseaeodorwithdrawal and  nonoseaeodorwithdrawal progressing to  nonoseaeodorwithdrawal  Should  nonoseaeaeonlyasinstruction appear likely, the patient should be taken immediately to a hospital for assessment and emptying of the pump reservoir.                               0                       1        1"
      ]
     },
     "execution_count": 62,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "overdose_df.head(n=10)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 39,
   "metadata": {},
   "outputs": [],
   "source": [
    "labeled_overdose_drugs = set(overdose_df['file'].values)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "18"
      ]
     },
     "execution_count": 29,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(labeled_overdose_drugs)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "overdose_nlpql = \n",
    "'''\n",
    "\n",
    "phenotype \"AE overdose/withdrawal terms\";\n",
    "\n",
    " include ClarityCore version \"1.0\" called Clarity;\n",
    "\n",
    " termset OverdoseTerms:\n",
    "    [\"overdose\", \"overdosing\", \"overdosed\", \"overdosage\", \"overdoses\", \"withdrawal\", \"withdrawing\", \"withdrawal\"];\n",
    "\n",
    "documentset Notes:\n",
    "Clarity.createReportTypeList([\"FDA Challenge Drug Label\"]);\n",
    "\n",
    "  define final OverdoseWithdrawalTerms:\n",
    "Clarity.ProviderAssertion({\n",
    "  termset: [OverdoseTerms],\n",
    "  documentset: [Notes]\n",
    "});\n",
    "'''"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 36,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>_id</th>\n",
       "      <th>batch</th>\n",
       "      <th>concept_code</th>\n",
       "      <th>end</th>\n",
       "      <th>experiencer</th>\n",
       "      <th>inserted_date</th>\n",
       "      <th>job_id</th>\n",
       "      <th>negation</th>\n",
       "      <th>nlpql_feature</th>\n",
       "      <th>owner</th>\n",
       "      <th>...</th>\n",
       "      <th>report_id</th>\n",
       "      <th>report_type</th>\n",
       "      <th>section</th>\n",
       "      <th>sentence</th>\n",
       "      <th>solr_id</th>\n",
       "      <th>source</th>\n",
       "      <th>start</th>\n",
       "      <th>subject</th>\n",
       "      <th>temporality</th>\n",
       "      <th>term</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>5c3f35485727ea01d7e4e21f</td>\n",
       "      <td>75</td>\n",
       "      <td>-1</td>\n",
       "      <td>63</td>\n",
       "      <td>Patient</td>\n",
       "      <td>2019-01-16 13:44:40.934000</td>\n",
       "      <td>1164</td>\n",
       "      <td>Affirmed</td>\n",
       "      <td>OverdoseWithdrawalTerms</td>\n",
       "      <td>claritynlp</td>\n",
       "      <td>...</td>\n",
       "      <td>FDA_AE_28</td>\n",
       "      <td>FDA Challenge Drug Label</td>\n",
       "      <td>UNKNOWN</td>\n",
       "      <td>Young animals were slightly more intolerant to acute overdosage and to subtle reductions in erythrocytes, platelets and leukocytes but were less sensitive to toxicity in the liver, kidney, thymus, and genitalia.</td>\n",
       "      <td>FDA_AE_28</td>\n",
       "      <td>FDA_AE_2019</td>\n",
       "      <td>53</td>\n",
       "      <td>BIAXIN</td>\n",
       "      <td>Recent</td>\n",
       "      <td>overdosage</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>5c3f35495727ea01dae4e21f</td>\n",
       "      <td>25</td>\n",
       "      <td>-1</td>\n",
       "      <td>161</td>\n",
       "      <td>Patient</td>\n",
       "      <td>2019-01-16 13:44:41.080000</td>\n",
       "      <td>1164</td>\n",
       "      <td>Affirmed</td>\n",
       "      <td>OverdoseWithdrawalTerms</td>\n",
       "      <td>claritynlp</td>\n",
       "      <td>...</td>\n",
       "      <td>FDA_AE_195</td>\n",
       "      <td>FDA Challenge Drug Label</td>\n",
       "      <td>SEIZURE_FAMILY_HISTORY</td>\n",
       "      <td>Prescriptions for Savella should be written for the smallest quantity of tablets consistent with good patient management, in order to reduce the risk of overdose.5.2 Serotonin Syndrome</td>\n",
       "      <td>FDA_AE_195</td>\n",
       "      <td>FDA_AE_2019</td>\n",
       "      <td>153</td>\n",
       "      <td>SAVELLA</td>\n",
       "      <td>Recent</td>\n",
       "      <td>overdose</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>5c3f35495727ea01dae4e220</td>\n",
       "      <td>25</td>\n",
       "      <td>-1</td>\n",
       "      <td>10</td>\n",
       "      <td>Patient</td>\n",
       "      <td>2019-01-16 13:44:41.084000</td>\n",
       "      <td>1164</td>\n",
       "      <td>Affirmed</td>\n",
       "      <td>OverdoseWithdrawalTerms</td>\n",
       "      <td>claritynlp</td>\n",
       "      <td>...</td>\n",
       "      <td>FDA_AE_195</td>\n",
       "      <td>FDA Challenge Drug Label</td>\n",
       "      <td>SEIZURE_FAMILY_HISTORY</td>\n",
       "      <td>Withdrawal symptoms have been reported in patients when discontinuing treatment with Savella.</td>\n",
       "      <td>FDA_AE_195</td>\n",
       "      <td>FDA_AE_2019</td>\n",
       "      <td>0</td>\n",
       "      <td>SAVELLA</td>\n",
       "      <td>Recent</td>\n",
       "      <td>Withdrawal</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>5c3f35495727ea01dae4e221</td>\n",
       "      <td>25</td>\n",
       "      <td>-1</td>\n",
       "      <td>138</td>\n",
       "      <td>Patient</td>\n",
       "      <td>2019-01-16 13:44:41.085000</td>\n",
       "      <td>1164</td>\n",
       "      <td>Affirmed</td>\n",
       "      <td>OverdoseWithdrawalTerms</td>\n",
       "      <td>claritynlp</td>\n",
       "      <td>...</td>\n",
       "      <td>FDA_AE_195</td>\n",
       "      <td>FDA Challenge Drug Label</td>\n",
       "      <td>SEIZURE_FAMILY_HISTORY</td>\n",
       "      <td>During marketing of milnacipran, and other SNRIs and SSRIs, there have been spontaneous reports of adverse events indicative of withdrawal and physical dependence occurring upon discontinuation of these drugs, particularly when discontinuation is abrupt.</td>\n",
       "      <td>FDA_AE_195</td>\n",
       "      <td>FDA_AE_2019</td>\n",
       "      <td>128</td>\n",
       "      <td>SAVELLA</td>\n",
       "      <td>Recent</td>\n",
       "      <td>withdrawal</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>5c3f35495727ea01dae4e222</td>\n",
       "      <td>25</td>\n",
       "      <td>-1</td>\n",
       "      <td>10</td>\n",
       "      <td>Patient</td>\n",
       "      <td>2019-01-16 13:44:41.085000</td>\n",
       "      <td>1164</td>\n",
       "      <td>Affirmed</td>\n",
       "      <td>OverdoseWithdrawalTerms</td>\n",
       "      <td>claritynlp</td>\n",
       "      <td>...</td>\n",
       "      <td>FDA_AE_195</td>\n",
       "      <td>FDA Challenge Drug Label</td>\n",
       "      <td>SEIZURE_FAMILY_HISTORY</td>\n",
       "      <td>Withdrawal symptoms have been reported in patients when discontinuing treatment with Savella.</td>\n",
       "      <td>FDA_AE_195</td>\n",
       "      <td>FDA_AE_2019</td>\n",
       "      <td>0</td>\n",
       "      <td>SAVELLA</td>\n",
       "      <td>Recent</td>\n",
       "      <td>Withdrawal</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>5 rows Ã 24 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                        _id  batch  concept_code  end experiencer               inserted_date  job_id  negation            nlpql_feature       owner     ...       report_id               report_type                 section                                                                                                                                                                                                                                                        sentence     solr_id       source start  subject temporality        term\n",
       "0  5c3f35485727ea01d7e4e21f     75            -1   63     Patient  2019-01-16 13:44:40.934000    1164  Affirmed  OverdoseWithdrawalTerms  claritynlp     ...       FDA_AE_28  FDA Challenge Drug Label                 UNKNOWN                                             Young animals were slightly more intolerant to acute overdosage and to subtle reductions in erythrocytes, platelets and leukocytes but were less sensitive to toxicity in the liver, kidney, thymus, and genitalia.   FDA_AE_28  FDA_AE_2019    53   BIAXIN      Recent  overdosage\n",
       "1  5c3f35495727ea01dae4e21f     25            -1  161     Patient  2019-01-16 13:44:41.080000    1164  Affirmed  OverdoseWithdrawalTerms  claritynlp     ...      FDA_AE_195  FDA Challenge Drug Label  SEIZURE_FAMILY_HISTORY                                                                        Prescriptions for Savella should be written for the smallest quantity of tablets consistent with good patient management, in order to reduce the risk of overdose.5.2 Serotonin Syndrome  FDA_AE_195  FDA_AE_2019   153  SAVELLA      Recent    overdose\n",
       "2  5c3f35495727ea01dae4e220     25            -1   10     Patient  2019-01-16 13:44:41.084000    1164  Affirmed  OverdoseWithdrawalTerms  claritynlp     ...      FDA_AE_195  FDA Challenge Drug Label  SEIZURE_FAMILY_HISTORY                                                                                                                                                                   Withdrawal symptoms have been reported in patients when discontinuing treatment with Savella.  FDA_AE_195  FDA_AE_2019     0  SAVELLA      Recent  Withdrawal\n",
       "3  5c3f35495727ea01dae4e221     25            -1  138     Patient  2019-01-16 13:44:41.085000    1164  Affirmed  OverdoseWithdrawalTerms  claritynlp     ...      FDA_AE_195  FDA Challenge Drug Label  SEIZURE_FAMILY_HISTORY  During marketing of milnacipran, and other SNRIs and SSRIs, there have been spontaneous reports of adverse events indicative of withdrawal and physical dependence occurring upon discontinuation of these drugs, particularly when discontinuation is abrupt.  FDA_AE_195  FDA_AE_2019   128  SAVELLA      Recent  withdrawal\n",
       "4  5c3f35495727ea01dae4e222     25            -1   10     Patient  2019-01-16 13:44:41.085000    1164  Affirmed  OverdoseWithdrawalTerms  claritynlp     ...      FDA_AE_195  FDA Challenge Drug Label  SEIZURE_FAMILY_HISTORY                                                                                                                                                                   Withdrawal symptoms have been reported in patients when discontinuing treatment with Savella.  FDA_AE_195  FDA_AE_2019     0  SAVELLA      Recent  Withdrawal\n",
       "\n",
       "[5 rows x 24 columns]"
      ]
     },
     "execution_count": 36,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "clarity_overdose_drugs_df = pd.read_csv('http://18.220.133.76:5000/job_results/1164/cohort')\n",
    "clarity_overdose_drugs_df.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 40,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "29"
      ]
     },
     "execution_count": 40,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "clarity_overdose_drugs = set([x.lower() for x in clarity_overdose_drugs_df['subject'].values])\n",
    "len(clarity_overdose_drugs)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 41,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'anoro',\n",
       " 'brilinta',\n",
       " 'daytrana',\n",
       " 'dexamethasone',\n",
       " 'effexor',\n",
       " 'effient',\n",
       " 'lexapro',\n",
       " 'lioresal',\n",
       " 'paxil',\n",
       " 'plavix',\n",
       " 'remeron',\n",
       " 'savella',\n",
       " 'seroquel',\n",
       " 'striverdi',\n",
       " 'valium',\n",
       " 'viibryd',\n",
       " 'vimpat',\n",
       " 'xarelto'}"
      ]
     },
     "execution_count": 41,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "labeled_overdose_drugs"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 42,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'arcalyst',\n",
       " 'belsomra',\n",
       " 'belviq',\n",
       " 'biaxin',\n",
       " 'daytrana',\n",
       " 'dexamethasone',\n",
       " 'effexor_xr',\n",
       " 'enbrel',\n",
       " 'hetlioz',\n",
       " 'kadcyla',\n",
       " 'latuda',\n",
       " 'lexapro',\n",
       " 'lioresal',\n",
       " 'movantik',\n",
       " 'paxil',\n",
       " 'pennsaid',\n",
       " 'prepopik',\n",
       " 'relistor',\n",
       " 'remeron',\n",
       " 'renvela',\n",
       " 'risperdal',\n",
       " 'sabril',\n",
       " 'savella',\n",
       " 'sensipar',\n",
       " 'seroquel',\n",
       " 'valium',\n",
       " 'victoza',\n",
       " 'vimpat',\n",
       " 'vyvanse'}"
      ]
     },
     "execution_count": 42,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "clarity_overdose_drugs"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 44,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'anoro',\n",
       " 'brilinta',\n",
       " 'effexor',\n",
       " 'effient',\n",
       " 'plavix',\n",
       " 'striverdi',\n",
       " 'viibryd',\n",
       " 'xarelto'}"
      ]
     },
     "execution_count": 44,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "not_found_in_clarity_drugs = labeled_overdose_drugs - clarity_overdose_drugs\n",
    "not_found_in_clarity_drugs"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 46,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>file</th>\n",
       "      <th>sent_id</th>\n",
       "      <th>sent_start</th>\n",
       "      <th>sent_end</th>\n",
       "      <th>sentence</th>\n",
       "      <th>notaecandidatecontraindication</th>\n",
       "      <th>nonoseaeodorwithdrawal</th>\n",
       "      <th>row_sum</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>90</th>\n",
       "      <td>brilinta</td>\n",
       "      <td>90</td>\n",
       "      <td>2933</td>\n",
       "      <td>2945</td>\n",
       "      <td>Stopping BRILINTA increases the risk of subsequent  nonoseaeodorwithdrawal [ see</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>100</th>\n",
       "      <td>brilinta</td>\n",
       "      <td>100</td>\n",
       "      <td>3301</td>\n",
       "      <td>3383</td>\n",
       "      <td>\\n', '\\n', '\\n', '\\n', '     5.4 Discontinuation of BRILINTA  \\n', '\\n', '\\n', '\\n', '   Discontinuation of BRILINTA will increase the risk of  nonoseaeodorwithdrawal   nonoseaeodorwithdrawal  and  nonoseaegeneralterm  If BRILINTA must be temporarily discontinued (e.g., to treat  nonoseaeaeonlyasinstruction or for significant surgery), restart it as soon as possible.</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "         file  sent_id  sent_start  sent_end                                                                                                                                                                                                                                                                                                                                                                           sentence  notaecandidatecontraindication  nonoseaeodorwithdrawal  row_sum\n",
       "90   brilinta       90        2933      2945                                                                                                                                                                                                                                                                                           Stopping BRILINTA increases the risk of subsequent  nonoseaeodorwithdrawal [ see                                       0                       1        1\n",
       "100  brilinta      100        3301      3383  \\n', '\\n', '\\n', '\\n', '     5.4 Discontinuation of BRILINTA  \\n', '\\n', '\\n', '\\n', '   Discontinuation of BRILINTA will increase the risk of  nonoseaeodorwithdrawal   nonoseaeodorwithdrawal  and  nonoseaegeneralterm  If BRILINTA must be temporarily discontinued (e.g., to treat  nonoseaeaeonlyasinstruction or for significant surgery), restart it as soon as possible.                               0                       1        1"
      ]
     },
     "execution_count": 46,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "brilinta =  overdose_df[overdose_df['file'].str.contains(\"brilinta\")]\n",
    "brilinta"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "with open('{}/ose_xml_training_20181101/{}.xml'.format(FDA_DIR, 'BRILINTA')) as f:\n",
    "    contents = f.read()\n",
    "\n",
    "print(contents)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 57,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>file</th>\n",
       "      <th>sent_id</th>\n",
       "      <th>sent_start</th>\n",
       "      <th>sent_end</th>\n",
       "      <th>sentence</th>\n",
       "      <th>notaecandidatecontraindication</th>\n",
       "      <th>nonoseaeodorwithdrawal</th>\n",
       "      <th>row_sum</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>113</th>\n",
       "      <td>effient</td>\n",
       "      <td>113</td>\n",
       "      <td>2528</td>\n",
       "      <td>2572</td>\n",
       "      <td>Discontinuing Effient, particularly in the first few weeks after  notaecandidatepreexistingconditionorriskfactor  increases the risk of subsequent  nonoseaeodorwithdrawal     5 WARNINGS AND PRECAUTIONS\\n', '\\n', '\\n', '\\n', '   EXCERPT:</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>140</th>\n",
       "      <td>effient</td>\n",
       "      <td>140</td>\n",
       "      <td>3840</td>\n",
       "      <td>3993</td>\n",
       "      <td>In patients who are managed with PCI and stent placement, premature discontinuation of any antiplatelet medication, including thienopyridines, conveys an increased risk of  nonoseaeodorwithdrawal   nonoseaeodorwithdrawal  and  nonoseaegeneralterm  Patients who require premature discontinuation of a thienopyridine will be at increased risk for  nonoseaeodorwithdrawal  Lapses in therapy should be avoided, and if thienopyridines must be temporarily discontinued because of an adverse event(s), they should be restarted as soon as possible [see Contraindications (  4.1  ,  4.2  ) and Warnings and Precautions (  5.1  )]  .\\n', '\\n', '\\n', '\\n', '    5.4 Thrombotic Thrombocytopenic Purpura\\n', '\\n', '\\n', '\\n', '   oselabeledaefromdruguse  has been reported with the use of Effient.</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "        file  sent_id  sent_start  sent_end                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            sentence  notaecandidatecontraindication  nonoseaeodorwithdrawal  row_sum\n",
       "113  effient      113        2528      2572                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Discontinuing Effient, particularly in the first few weeks after  notaecandidatepreexistingconditionorriskfactor  increases the risk of subsequent  nonoseaeodorwithdrawal     5 WARNINGS AND PRECAUTIONS\\n', '\\n', '\\n', '\\n', '   EXCERPT:                                   0                       1        1\n",
       "140  effient      140        3840      3993  In patients who are managed with PCI and stent placement, premature discontinuation of any antiplatelet medication, including thienopyridines, conveys an increased risk of  nonoseaeodorwithdrawal   nonoseaeodorwithdrawal  and  nonoseaegeneralterm  Patients who require premature discontinuation of a thienopyridine will be at increased risk for  nonoseaeodorwithdrawal  Lapses in therapy should be avoided, and if thienopyridines must be temporarily discontinued because of an adverse event(s), they should be restarted as soon as possible [see Contraindications (  4.1  ,  4.2  ) and Warnings and Precautions (  5.1  )]  .\\n', '\\n', '\\n', '\\n', '    5.4 Thrombotic Thrombocytopenic Purpura\\n', '\\n', '\\n', '\\n', '   oselabeledaefromdruguse  has been reported with the use of Effient.                                 0                       1        1"
      ]
     },
     "execution_count": 57,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "effient =  overdose_df[overdose_df['file'].str.contains(\"effient\")]\n",
    "effient"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 59,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'arcalyst',\n",
       " 'belsomra',\n",
       " 'belviq',\n",
       " 'biaxin',\n",
       " 'effexor_xr',\n",
       " 'enbrel',\n",
       " 'hetlioz',\n",
       " 'kadcyla',\n",
       " 'latuda',\n",
       " 'movantik',\n",
       " 'pennsaid',\n",
       " 'prepopik',\n",
       " 'relistor',\n",
       " 'renvela',\n",
       " 'risperdal',\n",
       " 'sabril',\n",
       " 'sensipar',\n",
       " 'victoza',\n",
       " 'vyvanse'}"
      ]
     },
     "execution_count": 59,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "only_clarity_found_drugs = clarity_overdose_drugs - labeled_overdose_drugs\n",
    "only_clarity_found_drugs"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 61,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'daytrana',\n",
       " 'dexamethasone',\n",
       " 'lexapro',\n",
       " 'lioresal',\n",
       " 'paxil',\n",
       " 'remeron',\n",
       " 'savella',\n",
       " 'seroquel',\n",
       " 'valium',\n",
       " 'vimpat'}"
      ]
     },
     "execution_count": 61,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "same_drugs = clarity_overdose_drugs.intersection(labeled_overdose_drugs)\n",
    "same_drugs"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 65,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'afinitor',\n",
       " 'androgel',\n",
       " 'aranesp',\n",
       " 'arcalyst',\n",
       " 'aubagio',\n",
       " 'avastin',\n",
       " 'belsomra',\n",
       " 'belviq',\n",
       " 'benlysta',\n",
       " 'biaxin',\n",
       " 'brilinta',\n",
       " 'carac',\n",
       " 'carboplatin',\n",
       " 'celebrex',\n",
       " 'cyramza',\n",
       " 'cytoxan',\n",
       " 'daytrana',\n",
       " 'dexamethasone',\n",
       " 'doxil',\n",
       " 'doxil_liposomal_',\n",
       " 'effexor',\n",
       " 'effexor_xr',\n",
       " 'effient',\n",
       " 'egrifta',\n",
       " 'enbrel',\n",
       " 'erbitux',\n",
       " 'folotyn',\n",
       " 'gazyva',\n",
       " 'genotropin',\n",
       " 'genotropin_preservative_free',\n",
       " 'hetlioz',\n",
       " 'impavido',\n",
       " 'inlyta',\n",
       " 'invokana',\n",
       " 'istodax',\n",
       " 'janumet',\n",
       " 'kadcyla',\n",
       " 'kyprolis',\n",
       " 'latuda',\n",
       " 'levaquin',\n",
       " 'lexapro',\n",
       " 'linzess',\n",
       " 'lioresal',\n",
       " 'lipitor',\n",
       " 'livalo',\n",
       " 'lynparza',\n",
       " 'mekinist',\n",
       " 'movantik',\n",
       " 'myrbetriq',\n",
       " 'onglyza',\n",
       " 'opsumit',\n",
       " 'paxil',\n",
       " 'pennsaid',\n",
       " 'plavix',\n",
       " 'prepopik',\n",
       " 'prograf',\n",
       " 'raxibacumab',\n",
       " 'relistor',\n",
       " 'remeron',\n",
       " 'remicade',\n",
       " 'renvela',\n",
       " 'risperdal',\n",
       " 'rituxan',\n",
       " 'sabril',\n",
       " 'savella',\n",
       " 'sensipar',\n",
       " 'seroquel',\n",
       " 'signifor',\n",
       " 'simponi',\n",
       " 'striverdi',\n",
       " 'thalomid',\n",
       " 'tradjenta',\n",
       " 'valium',\n",
       " 'victoza',\n",
       " 'viekira',\n",
       " 'viibryd',\n",
       " 'vimpat',\n",
       " 'votrient',\n",
       " 'vyvanse',\n",
       " 'xalkori',\n",
       " 'xarelto',\n",
       " 'xeljanz',\n",
       " 'xeloda',\n",
       " 'xofigo',\n",
       " 'xtandi',\n",
       " 'zaltrap'}"
      ]
     },
     "execution_count": 65,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "clarity_overdose_drugs_df = pd.read_csv('http://18.220.133.76:5000/job_results/1175/cohort')\n",
    "clarity_overdose_drugs = set([x.lower() for x in clarity_overdose_drugs_df['subject'].values])\n",
    "clarity_overdose_drugs"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 66,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'afinitor',\n",
       " 'aubagio',\n",
       " 'avastin',\n",
       " 'biaxin',\n",
       " 'carboplatin',\n",
       " 'cyramza',\n",
       " 'cytoxan',\n",
       " 'dexamethasone',\n",
       " 'doxil',\n",
       " 'doxil_liposomal_',\n",
       " 'folotyn',\n",
       " 'impavido',\n",
       " 'inlyta',\n",
       " 'istodax',\n",
       " 'kadcyla',\n",
       " 'kyprolis',\n",
       " 'lynparza',\n",
       " 'mekinist',\n",
       " 'opsumit',\n",
       " 'paxil',\n",
       " 'thalomid',\n",
       " 'tobi',\n",
       " 'valium',\n",
       " 'votrient',\n",
       " 'xalkori',\n",
       " 'xeloda'}"
      ]
     },
     "execution_count": 66,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "clarity_teratogenic_drugs_df = pd.read_csv('http://18.220.133.76:5000/job_results/1173/cohort')\n",
    "clarity_teratogenic_drugs = set([x.lower() for x in clarity_teratogenic_drugs_df['subject'].values])\n",
    "clarity_teratogenic_drugs"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 67,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'afinitor',\n",
       " 'aubagio',\n",
       " 'avastin',\n",
       " 'biaxin',\n",
       " 'carboplatin',\n",
       " 'celebrex',\n",
       " 'cyramza',\n",
       " 'cytoxan',\n",
       " 'dexamethasone',\n",
       " 'doxil',\n",
       " 'doxil_liposomal_',\n",
       " 'ella',\n",
       " 'folotyn',\n",
       " 'furosemide',\n",
       " 'impavido',\n",
       " 'inlyta',\n",
       " 'istodax',\n",
       " 'kadcyla',\n",
       " 'kyprolis',\n",
       " 'lexapro',\n",
       " 'lioresal',\n",
       " 'lynparza',\n",
       " 'mekinist',\n",
       " 'natroba',\n",
       " 'opsumit',\n",
       " 'paxil',\n",
       " 'pennsaid',\n",
       " 'premarin',\n",
       " 'prograf',\n",
       " 'remeron',\n",
       " 'remicade',\n",
       " 'sabril',\n",
       " 'seroquel',\n",
       " 'signifor',\n",
       " 'surfaxin',\n",
       " 'thalomid',\n",
       " 'tobi',\n",
       " 'valium',\n",
       " 'votrient',\n",
       " 'xalkori',\n",
       " 'xarelto',\n",
       " 'xeloda'}"
      ]
     },
     "execution_count": 67,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "clarity_pregnancy_drugs_df = pd.read_csv('http://18.220.133.76:5000/job_results/1172/cohort')\n",
    "clarity_pregnancy_drugs = set([x.lower() for x in clarity_pregnancy_drugs_df['subject'].values])\n",
    "clarity_pregnancy_drugs"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.5.2"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
